Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.

MLA

Morishima C, et al. “Hepatitis C Virus-Specific Immune Responses and Quasi-Species Variability at Baseline Are Associated with Nonresponse to Antiviral Therapy during Advanced Hepatitis C.” Journal of Infectious Diseases, vol. 193, no. 7, Apr. 2006, pp. 931–40. EBSCOhost, https://doi.org/10.1086/500952.

APA

Morishima C, Polyak SJ, Ray R, Doherty MC, Di Bisceglie AM, Malet PF, Bonkovsky HL, Sullivan DG, Gretch DR, Rothman AL, Koziel MJ, Lindsay KL, Hepatitis C Antiviral Long-Term Treatment against Cirrhosis Trial Group, Morishima, C., Polyak, S. J., Ray, R., Doherty, M. C., Di Bisceglie, A. M., Malet, P. F., & Bonkovsky, H. L. (2006). Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. Journal of Infectious Diseases, 193(7), 931–940. https://doi.org/10.1086/500952

Chicago

Morishima C, Polyak SJ, Ray R, Doherty MC, Di Bisceglie AM, Malet PF, Bonkovsky HL, et al. 2006. “Hepatitis C Virus-Specific Immune Responses and Quasi-Species Variability at Baseline Are Associated with Nonresponse to Antiviral Therapy during Advanced Hepatitis C.” Journal of Infectious Diseases 193 (7): 931–40. doi:10.1086/500952.